Literature DB >> 9886754

Inhibitory effect of digoxin on testosterone secretion through mechanisms involving decreases of cyclic AMP production and cytochrome P450scc activity in rat testicular interstitial cells.

H Lin1, S W Wang, S C Tsai, J J Chen, Y C Chiao, C C Lu, W J Huang, G J Wang, C F Chen, P S Wang.   

Abstract

1. In vivo and in vitro experiments were performed to examine inhibitory effects of digoxin on testosterone secretion and to determine possible underlying mechanisms. 2. A single intravenous injection of digoxin (1 microg kg(-1)) decreased the basal and human chorionic gonadotropin (hCG)-stimulated plasma testosterone concentrations in adult male rats. 3. Digoxin (10(-7) - 10(-4) M) decreased the basal and hCG-stimulated release of testosterone from rat testicular interstitial cells in vitro. 4. Digoxin (10(-7) - 10(-4) M) also diminished the basal and hCG-stimulated production of cyclic 3':5'-adenosine monophosphate (AMP) and attenuated the stimulatory effects of forskolin and 8-Br-cyclic AMP on testosterone production by rat testicular interstitial cells. 5. Digoxin (10(-4) M) inhibited cytochrome P450 side chain cleavage enzyme (cytochrome P450sec) activity (conversion of 25-hydroxy cholesterol to pregnenolone) in the testicular interstitial cells but did not influence the activity of other steroidogenic enzymes. 6. These results suggest that digoxin inhibits the production of testosterone in rat testicular interstitial cells, at least in part, via attenuation of the activities of adenylyl cyclase and cytochrome P450sec.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886754      PMCID: PMC1565747          DOI: 10.1038/sj.bjp.0702229

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Direct inhibitory effect of digitalis on progesterone release from rat granulosa cells.

Authors:  J J Chen; P S Wang; E J Chien; S W Wang
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Use of cardiac glycosides and risk of glioma.

Authors:  Corinna Seliger; Christoph R Meier; Susan S Jick; Martin Uhl; Ulrich Bogdahn; Peter Hau; M F Leitzmann
Journal:  J Neurooncol       Date:  2015-12-31       Impact factor: 4.130

3.  Is digoxin use for cardiovascular disease associated with risk of prostate cancer?

Authors:  Jonathan L Wright; Philip D Hansten; Janet L Stanford
Journal:  Prostate       Date:  2013-09-21       Impact factor: 4.104

4.  Direct effects of propylthiouracil on testosterone secretion in rat testicular interstitial cells.

Authors:  Y C Chiao; H Lin; S W Wang; P S Wang
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.

Authors:  Joseph M Langenhan; Noël R Peters; Ilia A Guzei; F Michael Hoffmann; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-16       Impact factor: 11.205

6.  Inhibitory effects of digoxin and digitoxin on corticosterone production in rat zona fasciculata-reticularis cells.

Authors:  Shyi-Wu Wang; Hsaio-Fung Pu; Shu-Fen Kan; Chiung-I Tseng; Ming-Jae Lo; Paulus S Wang
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

7.  Role of serum- and glucocorticoid-inducible kinase-1 in regulating torsion-induced apoptosis in rats.

Authors:  Y-M Cho; H-F Pu; W J Huang; L-T Ho; S-W Wang; P S Wang
Journal:  Int J Androl       Date:  2010-08-02

8.  Inhibitory Effects of Digoxin and Digitoxin on Cell Growth in Human Ovarian Cancer Cell Line SKOV-3.

Authors:  Jou-Chun Chou; Jie-Hau Li; Chih-Chieh Chen; Chien-Wei Chen; Ho Lin; Paulus S Wang
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

Review 9.  Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs.

Authors:  Dimitrios Terentes-Printzios; Nikolaos Ioakeimidis; Konstantinos Rokkas; Charalambos Vlachopoulos
Journal:  Nat Rev Cardiol       Date:  2021-07-30       Impact factor: 32.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.